Management of Beta Blockers in Severe Aortic Stenosis with Moderate Aortic Regurgitation

Introduction to Beta Blocker Use

The American College of Cardiology recommends that beta blockers should generally be avoided in patients with severe aortic stenosis and moderate aortic regurgitation, unless there is a compelling indication such as heart failure with reduced ejection fraction, post-myocardial infarction status, or significant arrhythmias 1, 2

The ACC/AHA explicitly states that in patients with chronic aortic insufficiency, treatment should avoid beta blockers to prevent slowing the heart rate, which is a Class IIa recommendation with Level C evidence 1
Beta blockers may be appropriate for patients with aortic stenosis who have reduced ejection fraction, prior myocardial infarction, arrhythmias requiring rate control, or angina pectoris 1, 2

When managing patients with both severe aortic stenosis and moderate aortic regurgitation, prioritize the aortic regurgitation concern unless heart failure with reduced ejection fraction, recent myocardial infarction, or life-threatening arrhythmias are present 2
In scenarios without these compelling indications, choose alternative antihypertensive agents, with first-line treatment being RAS inhibitors such as ACE-I or ARBs, due to their beneficial effects on left ventricular fibrosis, blood pressure control, dyspnea reduction, and improved effort tolerance 1, 2

Mandatory cardiology consultation or co-management is recommended for hypertension management in patients with moderate-to-severe aortic stenosis, particularly when complicated by concurrent valvular lesions, to balance competing hemodynamic concerns 1, 2